Claims
- 1. A method of treating inflammation in humans and animals which comprises topically applying to the inflamed area an anti-inflammatory amount of a composition which comprises from about 0.1% to about 10.0% of phenyl salicylate in combination with a pharmaceutically acceptable carrier suitable for topical application to the skin of a human or animal.
- 2. A method according to claim 1 wherein the concentration of phenyl salicylate is from about 1.0% to about 10.0%.
- 3. A method according to claim 1 wherein the concentration of phenyl salicylate is from about 1.0% to about 5.0%.
- 4. A method according to claim 1 wherein the concentration of phenyl salicylate is from about 0.1% to about 2.5%.
- 5. A method according to claim 1 wherein the concentration of phenyl salicylate is from about 3.0% to about 5.0%.
- 6. A method according to claim 1 wherein the concentration of phenyl salicylate is about 1%.
- 7. A method according to claim 1 wherein the carrier is a lower alkanol.
- 8. A method according to claim 7 wherein the lower alkanol is ethanol.
- 9. A method according to claim 1 wherein the carrier is benzyl alcohol.
- 10. A method according to claim 1 wherein the carrier is propylene glycol.
- 11. A method according to claim 1 wherein the concentration of phenyl salicylate is about 1.0% and the carrier is a mixture of benzyl alcohol, propylene glycol, isopropyl alcohol and absolute ethyl alcohol.
- 12. A method according to claim 1 wherein the concentration of phenyl salicylate is about 2.5% to 3.0% and the carrier is a mixture of propylene glycol and absolute ethyl alcohol.
- 13. A method according to claim 1 wherein the concentration of phenyl salicylate is about 5.0% and the carrier is a mixture of propylene glycol and absolute ethyl alcohol.
- 14. A method according to claim 1 wherein the concentration of phenyl salicylate is about 5.0% and the carrier is absolute ethyl alcohol.
- 15. A method according to claim 1 wherein the concentration of phenyl salicylate is about 10.0% and the carrier is a mixture of benzyl alcohol, propylene glycol and absolute ethyl alcohol.
- 16. A method according to claim 1 wherein the concentration of phenyl salicylate is about 1% and the carrier is a lower alkanol or propylene glycol.
Parent Case Info
This is a continuation-in-part of my co-pending application Ser. No. 142,873 filed Apr. 23, 1980 now abandoned which is itself a continuation of my application Ser. No. 005,963 filed Jan. 24, 1979, now abandoned.
US Referenced Citations (6)
Non-Patent Literature Citations (2)
Entry |
The Merck Index, 9th ed. (1976)-Merck & Co. Inc. item 7116. |
Chem. Abst. 38, 6490 (1) (1944)-Termansen. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
5963 |
Jan 1979 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
142873 |
Apr 1980 |
|